Homology Modelling of Two Subtilisin-Like Serine Proteases from the Hyperthermophilic Archaea Pyrococcus Furiosus and Thermococcus Stetteri
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
(12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002
USOO6395889B1 (12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002 (54) NUCLEIC ACID MOLECULES ENCODING WO WO-98/56804 A1 * 12/1998 ........... CO7H/21/02 HUMAN PROTEASE HOMOLOGS WO WO-99/0785.0 A1 * 2/1999 ... C12N/15/12 WO WO-99/37660 A1 * 7/1999 ........... CO7H/21/04 (75) Inventor: fish E. Robison, Wilmington, MA OTHER PUBLICATIONS Vazquez, F., et al., 1999, “METH-1, a human ortholog of (73) Assignee: Millennium Pharmaceuticals, Inc., ADAMTS-1, and METH-2 are members of a new family of Cambridge, MA (US) proteins with angio-inhibitory activity', The Journal of c: - 0 Biological Chemistry, vol. 274, No. 33, pp. 23349–23357.* (*) Notice: Subject to any disclaimer, the term of this Descriptors of Protease Classes in Prosite and Pfam Data patent is extended or adjusted under 35 bases. U.S.C. 154(b) by 0 days. * cited by examiner (21) Appl. No.: 09/392, 184 Primary Examiner Ponnathapu Achutamurthy (22) Filed: Sep. 9, 1999 ASSistant Examiner William W. Moore (51) Int. Cl." C12N 15/57; C12N 15/12; (74) Attorney, Agent, or Firm-Alston & Bird LLP C12N 9/64; C12N 15/79 (57) ABSTRACT (52) U.S. Cl. .................... 536/23.2; 536/23.5; 435/69.1; 435/252.3; 435/320.1 The invention relates to polynucleotides encoding newly (58) Field of Search ............................... 536,232,235. identified protease homologs. The invention also relates to 435/6, 226, 69.1, 252.3 the proteases. The invention further relates to methods using s s s/ - - -us the protease polypeptides and polynucleotides as a target for (56) References Cited diagnosis and treatment in protease-mediated disorders. -
B1–Proteases As Molecular Targets of Drug Development
Abstracts B1–Proteases as Molecular Targets of Drug Development B1-001 lin release from the beta cells. Furthermore, GLP-1 also stimu- DPP-IV structure and inhibitor design lates beta cell growth and insulin biosynthesis, inhibits glucagon H. B. Rasmussen1, S. Branner1, N. Wagtmann3, J. R. Bjelke1 and secretion, reduces free fatty acids and delays gastric emptying. A. B. Kanstrup2 GLP-1 has therefore been suggested as a potentially new treat- 1Protein Engineering, Novo Nordisk A/S, Bagsvaerd, Denmark, ment for type 2 diabetes. However, GLP-1 is very rapidly degra- 2Medicinal Chemistry, Novo Nordisk A/S, Maaloev, Denmark, ded in the bloodstream by the enzyme dipeptidyl peptidase IV 3Discovery Biology, Novo Nordisk A/S, Maaloev, DENMARK. (DPP-IV; EC 3.4.14.5). A very promising approach to harvest E-mail: [email protected] the beneficial effect of GLP-1 in the treatment of diabetes is to inhibit the DPP-IV enzyme, thereby enhancing the levels of The incretin hormones GLP-1 and GIP are released from the gut endogenously intact circulating GLP-1. The three dimensional during meals, and serve as enhancers of glucose stimulated insu- structure of human DPP-IV in complex with various inhibitors 138 Abstracts creates a better understanding of the specificity and selectivity of drug-like transition-state inhibitors but can be utilized for the this enzyme and allows for further exploration and design of new design of non-transition-state inhibitors that compete for sub- therapeutic inhibitors. The majority of the currently known DPP- strate binding. Besides carrying out proteolytic activity, the IV inhibitors consist of an alpha amino acid pyrrolidine core, to ectodomain of memapsin 2 also interacts with APP leading to which substituents have been added to optimize affinity, potency, the endocytosis of both proteins into the endosomes where APP enzyme selectivity, oral bioavailability, and duration of action. -
Serine Proteases with Altered Sensitivity to Activity-Modulating
(19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants. -
Subtilase Variants
(19) & (11) EP 2 333 055 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 15.06.2011 Bulletin 2011/24 C12N 9/54 (2006.01) C11D 3/386 (2006.01) C12N 1/15 (2006.01) C12N 1/19 (2006.01) (2006.01) (21) Application number: 10180093.6 C12N 1/21 (22) Date of filing: 12.10.2001 (84) Designated Contracting States: (72) Inventors: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU • Nørregaard-Madsen, Mads MC NL PT SE TR DK-3560, Birkerød (DK) • Larsen, Line, Bloch (30) Priority: 13.10.2000 DK 200001528 DK-2880, Bagsværd (DK) • Hansen, Peter Kamp (62) Document number(s) of the earlier application(s) in DK-4320, Lejre (DK) accordance with Art. 76 EPC: 01978206.9 / 1 326 966 Remarks: This application was filed on 27-09-2010 as a (71) Applicant: Novozymes A/S divisional application to the application mentioned 2880 Bagsvaerd (DK) under INID code 62. (54) Subtilase variants (57) Novel subtilase variants having a reduced ten- dry detergent compositions and dishwash composition, dency towards inhibition by substances present in eggs, including automatic dishwash compositions. Also, isolat- such as trypsin inhibitor type IV- 0. In particular, variants ed DNA sequences encoding the variants, expression comprising at least one additional amino acid residue vectors, host cells, and methods for producing and using between positions 42-43, 51-56, 155-161, 187-190, the variants of the invention. Further, cleaning and de- 216-217, 217-218 or 218-219 (in BASBPN numbering). tergent compositions comprising the variants are dis- These subtilase variants are useful exhibiting excellent closed. -
Proquest Dissertations
urn u Ottawa L'Universitd canadienne Canada's university FACULTE DES ETUDES SUPERIEURES l^^l FACULTY OF GRADUATE AND ET POSTDOCTORALES u Ottawa POSTDOCTORAL STUDIES I.'University emiadienne Canada's university Charles Gyamera-Acheampong AUTEUR DE LA THESE / AUTHOR OF THESIS Ph.D. (Biochemistry) GRADE/DEGREE Biochemistry, Microbiology and Immunology FACULTE, ECOLE, DEPARTEMENT / FACULTY, SCHOOL, DEPARTMENT The Physiology and Biochemistry of the Fertility Enzyme Proprotein Convertase Subtilisin/Kexin Type 4 TITRE DE LA THESE / TITLE OF THESIS M. Mbikay TIRECTWRTDIRICTR^ CO-DIRECTEUR (CO-DIRECTRICE) DE LA THESE / THESIS CO-SUPERVISOR EXAMINATEURS (EXAMINATRICES) DE LA THESE/THESIS EXAMINERS A. Basak G. Cooke F .Kan V. Mezl Gary W. Slater Le Doyen de la Faculte des etudes superieures et postdoctorales / Dean of the Faculty of Graduate and Postdoctoral Studies Library and Archives Bibliotheque et 1*1 Canada Archives Canada Published Heritage Direction du Branch Patrimoine de I'edition 395 Wellington Street 395, rue Wellington OttawaONK1A0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre reference ISBN: 978-0-494-59504-6 Our file Notre reference ISBN: 978-0-494-59504-6 NOTICE: AVIS: The author has granted a non L'auteur a accorde une licence non exclusive exclusive license allowing Library and permettant a la Bibliotheque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par I'lnternet, prefer, telecommunication or on the Internet, distribuer et vendre des theses partout dans le loan, distribute and sell theses monde, a des fins commerciales ou autres, sur worldwide, for commercial or non support microforme, papier, electronique et/ou commercial purposes, in microform, autres formats. -
Fibronectin-Binding Protein B (Fnbpb)
ARTICLE cro Fibronectin-binding protein B (FnBPB) from Staphylococcus aureus protects against the antimicrobial activity of histones Received for publication, September 5, 2018, and in revised form, December 17, 2018 Published, Papers in Press, January 8, 2019, DOI 10.1074/jbc.RA118.005707 X Giampiero Pietrocola‡1, Giulia Nobile‡, Mariangela J. Alfeo‡, Timothy J. Foster§, Joan A. Geoghegan¶, Vincenzo De Filippisʈ, and X Pietro Speziale‡**2 From the ‡Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, 27100 Pavia, Italy, the §Microbiology Department, Trinity College Dublin, Dublin 2, Ireland, the ¶Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College, Dublin, Dublin 2, Ireland, the ʈLaboratory of Protein Chemistry and Molecular Hematology, Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 36131 Padova, Italy, and the **Department of Industrial and Information Engineering, University of Pavia, 27100 Pavia, Italy Edited by Roger J. Colbran Staphylococcus aureus is a Gram-positive bacterium that can tizing pneumoniae (1, 2). Strains that are resistant to multiple Downloaded from cause both superficial and deep-seated infections. Histones antibiotics are a major problem in healthcare settings in devel- released by neutrophils kill bacteria by binding to the bacterial oped countries (3). These are referred to as hospital-associated cell surface and causing membrane damage. We postulated that methicillin-resistant S. aureus (MRSA)3 and occur in individu- cell wall–anchored proteins protect S. aureus from the bacteri- als with pre-disposing risk factors, such as surgical wounds and cidal effects of histones by binding to and sequestering histones indwelling medical devices (4, 5). -
Characterisation of the Major Extracellular Proteases of Stenotrophomonas Maltophilia and Their Effects on Pulmonary Antiproteases
pathogens Article Characterisation of the Major Extracellular Proteases of Stenotrophomonas maltophilia and Their Effects on Pulmonary Antiproteases Kevin Molloy 1, Stephen G. Smith 2, Gerard Cagney 3, Eugene T. Dillon 3, Catherine M. Greene 4,* and Noel G. McElvaney 1 1 Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, D02 YN77 Dublin, Ireland 2 Department of Clinical Microbiology, School of Medicine, Trinity College Dublin, D02 PN40 Dublin, Ireland 3 School of Biomolecular and Biomedical Science, University College Dublin, D04 V1W8 Dublin, Ireland 4 Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Beaumont Hospital, D02 YN77 Dublin, Ireland * Correspondence: [email protected] Received: 31 May 2019; Accepted: 22 June 2019; Published: 28 June 2019 Abstract: Stenotrophomonas maltophilia is an emerging global opportunistic pathogen that has been appearing with increasing prevalence in cystic fibrosis (CF). A secreted protease from S. maltophilia has been reported as its chief potential virulence factor. Here, using the reference clinical strain S. maltophilia K279a, the major secreted proteases were identified. Protein biochemistry and mass spectrometry were carried out on K279a culture supernatant. The effect of K279a culture supernatant on cleavage and anti-neutrophil elastase activity of the three majors pulmonary antiproteases was quantified. A deletion mutant of S. maltophilia lacking expression of a protease was constructed. The serine proteases StmPR1, StmPR2 and StmPR3, in addition to chitinase A and an outer membrane esterase were identified in culture supernatants. Protease activity was incompletely abrogated in a K279a-DStmPR1: Erm mutant. Wild type K279a culture supernatant degraded alpha-1 antitrypsin (AAT), secretory leucoprotease inhibitor (SLPI) and elafin, important components of the lung’s innate immune defences. -
The Utilization of Alpha-1 Anti-Trypsin (A1AT) in Infectious Disease Monitoring and Treatment Irene L
JMID/ 2019; 9 (1):51-58 Journal of Microbiology and Infectious Diseases doi: 10.5799/jmid.537178 REVIEW ARTICLE The Utilization of Alpha-1 Anti-trypsin (A1AT) in Infectious Disease Monitoring and Treatment Irene L. Indalao, Agustiningsih Agustiningsih, Eka Pratiwi, Kartika Dewi Puspa, Hartanti Dian Ikawati, Ririn Ramadhany Center for Research and Development of Biomedical and Basic Technology of Health, National Institute of Health Research and Development, Ministry of Health Republic of Indonesia ABSTRACT Alpha one anti-trypsin (A1AT) is a major serine protease inhibitor found circulating in human blood. A1AT related studies mainly focus on A1AT potential biomarker as well as therapeutic target in non-infectious diseases. Their findings indicate A1AT beneficial features may also be applied for monitoring and treating infectious disease. However, only a few studies have reviewed A1AT’s useful properties as a biomarker and therapeutic agent for infectious diseases. This narrative review aims to summarize growing evidences that support the idea of utilizing A1AT as a tool for monitoring and therapy for infectious diseases. A1AT showed potential as a biomarker for a wide spectrum of infectious disease, from virus, bacteria, to parasite. Its level and functionality were proposed to predict risk for disease susceptibility or progression and to indicate response therapy. As promising therapeutic agent in various infectious diseases, the administration of A1AT has shown antimicrobial activity, immunomodulatory and anti-apoptotic effect, in addition to more familiar function, suppressing excessive proteolysis. The broad utilization of A1AT, both as biomarker and therapeutic agent, in studies on infectious diseases seems promising. However, there are issues need to be investigated further before establishing its feasibility as a monitoring and therapy tool against infection diseases. -
Studies of Structure and Function of Tripeptidyl-Peptidase II
Till familj och vänner List of Papers This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I. Eriksson, S.; Gutiérrez, O.A.; Bjerling, P.; Tomkinson, B. (2009) De- velopment, evaluation and application of tripeptidyl-peptidase II se- quence signatures. Archives of Biochemistry and Biophysics, 484(1):39-45 II. Lindås, A-C.; Eriksson, S.; Josza, E.; Tomkinson, B. (2008) Investiga- tion of a role for Glu-331 and Glu-305 in substrate binding of tripepti- dyl-peptidase II. Biochimica et Biophysica Acta, 1784(12):1899-1907 III. Eklund, S.; Lindås, A-C.; Hamnevik, E.; Widersten, M.; Tomkinson, B. Inter-species variation in the pH dependence of tripeptidyl- peptidase II. Manuscript IV. Eklund, S.; Kalbacher, H.; Tomkinson, B. Characterization of the endopeptidase activity of tripeptidyl-peptidase II. Manuscript Paper I and II were published under maiden name (Eriksson). Reprints were made with permission from the respective publishers. Contents Introduction ..................................................................................................... 9 Enzymes ..................................................................................................... 9 Enzymes and pH dependence .............................................................. 11 Peptidases ................................................................................................. 12 Serine peptidases ................................................................................. 14 Intracellular protein -
University of California Riverside
UNIVERSITY OF CALIFORNIA RIVERSIDE Mechanisms of Selenomethionine and Hypersaline Developmental Toxicity in Japanese Medaka (Oryzias latipes) A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Environmental Toxicology by Allison Justine Kupsco August 2016 Dissertation Committee: Dr. Daniel Schlenk, Chairperson Dr. Morris Maduro Dr. Nicole zur Nieden Copyright by Allison Justine Kupsco 2016 The Dissertation of Allison Justine Kupsco is approved: Committee Chairperson University of California, Riverside Acknowledgements This dissertation would not have been possible without the support of many people. First, my advisor, Dr. Dan Schlenk, was invaluable in not only his guidance and resources for this project, but also in providing me with the opportunities to grow and develop as a scientist. Without the time and effort he put into guiding me, this would not have been possible. In addition to advice about this dissertation, he also provided me with numerous networking and presentation opportunities through attendance of many conferences. I would also like to thank my committee members, Dr. Nicole zur Nieden and Dr. Morris Maduro for their support and advice. There have been many past and present labmates that have also aided in the dissertation through training, advice and emotional support. Dr. Aileen Maldonado, Dr. Lindley Maryoung, and Dr. Jordan Crago all participated in training me in lab techniques. Rafid Sikder was always eager to help and assisted in fish care and in data collected in Chapter 2. Luisa Becker Bertotto, Scott Coffin, Marissa Giroux and Sara Vliet provided important emotional support and entertainment during long lab hours. And especially, I want to thank Graciel Diamante for her invaluable advice, commiseration and emotional support throughout our 4 years working together. -
An Arabidopsis Mutant Over-Expressing Subtilase SBT4.13 Uncovers the Role of Oxidative Stress in the Inhibition of Growth by Intracellular Acidification
International Journal of Molecular Sciences Article An Arabidopsis Mutant Over-Expressing Subtilase SBT4.13 Uncovers the Role of Oxidative Stress in the Inhibition of Growth by Intracellular Acidification Gaetano Bissoli 1 , Jesús Muñoz-Bertomeu 2 , Eduardo Bueso 1, Enric Sayas 1, Edgardo A. Vilcara 1, Amelia Felipo 1, Regina Niñoles 1 , Lourdes Rubio 3 , José A. Fernández 3 and Ramón Serrano 1,* 1 Instituto de Biología Molecular y Celular de Plantas, Universidad Politécnica de Valencia-Consejo Superior de Investigaciones Científicas, Camino de Vera, 46022 Valencia, Spain 2 Departament de Biologia Vegetal, Facultat de Farmàcia, Universitat de València, 46100 València, Spain 3 Departamento de Botánica y Fisiología Vegetal, Universidad de Málaga, 29071 Málaga, Spain * Correspondence: [email protected] Received: 30 January 2020; Accepted: 8 February 2020; Published: 10 February 2020 Abstract: Intracellular acid stress inhibits plant growth by unknown mechanisms and it occurs in acidic soils and as consequence of other stresses. In order to identify mechanisms of acid toxicity, we screened activation-tagging lines of Arabidopsis thaliana for tolerance to intracellular acidification induced by organic acids. A dominant mutant, sbt4.13-1D, was isolated twice and shown to over-express subtilase SBT4.13, a protease secreted into endoplasmic reticulum. Activity measurements and immuno-detection indicate that the mutant contains less plasma membrane H+-ATPase (PMA) than wild type, explaining the small size, electrical depolarization and decreased cytosolic pH of the mutant but not organic acid tolerance. Addition of acetic acid to wild-type plantlets induces production of ROS (Reactive Oxygen Species) measured by dichlorodihydrofluorescein diacetate. Acid-induced ROS production is greatly decreased in sbt4.13-1D and atrboh-D,F mutants. -
The Tomato Subtilase Family Includes Several Cell Death-Related Proteinases with Caspase Specificity
www.nature.com/scientificreports Corrected: Author Correction OPEN The tomato subtilase family includes several cell death-related proteinases with caspase specifcity Received: 10 April 2018 Sven Reichardt1, Dagmar Repper1, Alexander I. Tuzhikov2, Raisa A. Galiullina2, Accepted: 29 June 2018 Marc Planas-Marquès3, Nina V. Chichkova2, Andrey B. Vartapetian2, Annick Stintzi 1 & Published online: 12 July 2018 Andreas Schaller 1 Phytaspases are Asp-specifc subtilisin-like plant proteases that have been likened to animal caspases with respect to their regulatory function in programmed cell death (PCD). We identifed twelve putative phytaspase genes in tomato that difered widely in expression level and tissue-specifc expression patterns. Most phytaspase genes are tandemly arranged on tomato chromosomes one, four, and eight, and many belong to taxon-specifc clades, e.g. the P69 clade in the nightshade family, suggesting that these genes evolved by gene duplication after speciation. Five tomato phytaspases (SlPhyts) were expressed in N. benthamiana and purifed to homogeneity. Substrate specifcity was analyzed in a proteomics assay and with a panel of fuorogenic peptide substrates. Similar to animal caspases, SlPhyts recognized an extended sequence motif including Asp at the cleavage site. Clear diferences in cleavage site preference were observed implying diferent substrates in vivo and, consequently, diferent physiological functions. A caspase-like function in PCD was confrmed for fve of the seven tested phytaspases. Cell death was triggered by ectopic expression of SlPhyts 2, 3, 4, 5, 6 in tomato leaves by agro-infltration, as well as in stably transformed transgenic tomato plants. SlPhyts 3, 4, and 5 were found to contribute to cell death under oxidative stress conditions.